Africa Pharmaceuticals Market: By Product Type, By Formulation, By Therapeutic Area, By Distribution Channel, and Geography
Africa Pharmaceuticals Market size was valued at US$ x billion in 2023 and is expected to reach US$ x billion by 2030, at a CAGR of x% from 2024-2030. In addition, expansion of businesses by the pharmaceutical companies, environmental conditions such as tropical climate in Africa may cause the infectious diseases such as TB, malaria, and AIDS, and economic growth are expected to propel the Africa pharmaceuticals market. However, high cost of pharmaceuticals for chronic diseases, and lack of awareness about the disease treatments in underdeveloped countries may hamper the growth.
Increase in the prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, rise in R&D activities for the innovation of newer drugs, and increase in healthcare expenditure are anticipated to fuel the Africa pharmaceuticals market over the forecast period.
Geographically, Africa pharmaceuticals market is segmented into North Africa, Central Africa, South Africa, and rest of Africa. North Africa pharmaceuticals market is growing at a significant rate owing to increase in the prevalence of malaria, leishmaniasis, rickettsioses, and leishmaniasis in Algeria, Egypt, Libya, and Tunisia. Central Africa pharmaceuticals market has a lucrative growth owing to rise in prevalence of malaria, cholera, and tuberculosis due to tropical climate, rise in incidence of AIDS especially in women, and rapid urbanization are boost the market. Southern Africa pharmaceuticals market has a significant share attributed to awareness about diseases treatment majorly in South Africa, rise in R&D for the innovation of newer drugs, and expansion of business by market players in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Product Type |
|
|
By Formulation |
|
|
By Therapeutic Area |
|
|
By Distribution Channel |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The africa pharmaceuticals market key players are GlaxoSmithKline Plc, Pfizer Inc, Novartis AG, Sanofi S.A., Litha Healthcare Group
| 1.Executive Summary |
| 2. Africa Pharmaceuticals Market Introduction |
| 2.1. Africa Pharmaceuticals Market - Taxonomy |
| 2.2. Africa Pharmaceuticals Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Formulation |
| 2.2.3.Therapeutic Area |
| 2.2.4.Distribution Channel |
| 3. Africa Pharmaceuticals Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Africa Pharmaceuticals Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Africa Pharmaceuticals Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Prescription Drugs |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Over-the-Counter Drugs |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Africa Pharmaceuticals Market By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Solid |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Liquid |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Semi-Solid |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Africa Pharmaceuticals Market By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Infectious Diseases |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiovascular Diseases |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diabetes and Metabolic Disorders |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Neurological Diseases |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Cancer |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Autoimmune Disorders |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8. Africa Pharmaceuticals Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9. Competition Landscape |
| 9.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 9.2.1.GlaxoSmithKline Plc. |
| 9.2.2.Pfizer Inc. |
| 9.2.3.Novartis AG |
| 9.2.4.Sanofi S.A. |
| 9.2.5.AstraZeneca plc |
| 9.2.6.Cipla Ltd. |
| 9.2.7.Bayer AG |
| 9.2.8.Resmed Pharmaceuticals |
| 9.2.9.Aspen Holdings |
| 9.2.10.Litha Healthcare Group (Pty) Ltd |
| 10. Research Methodology |
| 11. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
